4//SEC Filing
Salka Michael Scott 4
Accession 0001181431-12-030300
CIK 0000850261other
Filed
May 15, 8:00 PM ET
Accepted
May 16, 4:21 PM ET
Size
6.3 KB
Accession
0001181431-12-030300
Insider Transaction Report
Form 4
Salka Michael Scott
Director
Transactions
- Purchase
Call Option (right to buy)
2012-05-15+300,000→ 300,000 totalExercise: $0.16Exp: 2022-05-15→ Common Stock (300,000 underlying)
Footnotes (2)
- [F1]The Reporting Person purchased the call option (the "Option") for no consideration pursuant to a grant of such Option made by SDL Ventures, LLC, which is controlled by Donald R. Scifres ("Scifres"), on May 15, 2012. The Option entitles the Reporting Person to purchase shares of Sorrento Therapeutics, Inc. ("Sorrento") for $0.16 per share, subject to vesting, as described in footnote 2. The common stock of Sorrento underlying the Option may be deemed to have been purchased on December 29, 2011 by Donald R. Scifres 2011 Annuity Trust, which is controlled by Scifres, for a purchase price of $0.16 per share.
- [F2]One third of the shares underlying the Option shall vest on February 15, 2013, subject to the Reporting Person's continuous service on Sorrento's board of directors through such date, and the remainder of the shares underlying the Option shall vest in equal monthly installments over the remaining 24 months thereafter, subject to the Reporting Person's continuous service on Sorrento's board of directors through each such vesting date.
Documents
Issuer
Sorrento Therapeutics, Inc.
CIK 0000850261
Entity typeother
Related Parties
1- filerCIK 0001542981
Filing Metadata
- Form type
- 4
- Filed
- May 15, 8:00 PM ET
- Accepted
- May 16, 4:21 PM ET
- Size
- 6.3 KB